Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer
Wisselink, Daan D; Braakhuis, Linde L F; Gallo, Gaetano; van Grevenstein, Wilhelmina M U; van Dieren, Susan; Kok, Niels F M; de Reuver, Philip R; Tanis, Pieter J; de Hingh, Ignace H J T
(2019) Critical Reviews in Oncology/Hematology, volume 142, pp. 119 - 129
(Article)
Abstract
BACKGROUND: The role of hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin in addition to cytoreductive surgery (CRS) has recently been questioned in peritoneal metastases of colorectal cancer. Whether this applies to all published CRS/HIPEC regimens is unclear. METHODS: A systematic literature search identified 46 studies on CRS/HIPEC using either oxaliplatin of
... read more
mitomycin C with at least one oncological outcome parameter RESULTS: Oxaliplatin and mitomycin C studies were comparable regarding extent of disease, but differed substantially regarding synchronous versus metachronous presentation, application of neo-adjuvant systemic chemotherapy, duration of HIPEC, and completeness of cytoreduction for at least one of the oncological endpoints. Severe postoperative complication rate seemed significantly higher after oxaliplatin-based CRS/HIPEC. CONCLUSION: Published cohorts on oxaliplatin-based CRS/HIPEC differed essentially from MMC-based procedures, especially considering the application of oxaliplatin-containing neo-adjuvant systemic therapy and shorter exposure time to intraperitoneal chemotherapy in oxaliplatin studies. No meaningful comparison could be made regarding DFS and OS.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Antineoplastic Agents/therapeutic use, Colorectal Neoplasms/drug therapy, Combined Modality Therapy, Cytoreduction Surgical Procedures, Humans, Hyperthermia, Induced, Mitomycin/therapeutic use, Oxaliplatin/therapeutic use, Peritoneal Neoplasms/drug therapy, Cytoreductive surgery, Colorectal cancer, Survival, Morbidity, Oxaliplatin, HIPEC, Mitomycin C, Peritoneal metastases, Hematology, Oncology, Meta-Analysis, Journal Article, Comparative Study
ISSN: 1040-8428
Publisher: Elsevier Ireland Ltd
Note: Funding Information: Unrestricted scientific grant of the Dutch Cancer Society. The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication. Publisher Copyright: © 2019 Elsevier B.V.
(Peer reviewed)